Envision Healthcare (NYSE:EVHC) has been assigned a $40.00 price target by analysts at SunTrust Banks in a research report issued on Thursday. The firm currently has a “buy” rating on the stock. SunTrust Banks’ target price suggests a potential upside of 15.87% from the company’s previous close.
Several other equities analysts have also commented on EVHC. Jefferies Group set a $71.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Thursday, August 24th. Bank of America lowered their price objective on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, October 9th. Robert W. Baird reissued a “buy” rating and set a $70.00 price objective on shares of Envision Healthcare in a research report on Tuesday, October 17th. Cantor Fitzgerald lowered Envision Healthcare from an “overweight” rating to a “neutral” rating and set a $30.00 price objective for the company. in a research report on Wednesday, November 1st. Finally, KeyCorp set a $67.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research report on Wednesday, November 1st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $43.25.
Envision Healthcare (NYSE EVHC) opened at $34.52 on Thursday. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $3,943.41, a price-to-earnings ratio of 10.07, a price-to-earnings-growth ratio of 1.06 and a beta of 0.57. Envision Healthcare has a 52-week low of $23.77 and a 52-week high of $73.00.
Envision Healthcare declared that its board has initiated a stock repurchase program on Monday, September 18th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board of directors believes its shares are undervalued.
Institutional investors and hedge funds have recently bought and sold shares of the company. Commonwealth Bank of Australia raised its position in shares of Envision Healthcare by 24.3% in the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after purchasing an additional 410 shares during the last quarter. Cutter & CO Brokerage Inc. raised its position in shares of Envision Healthcare by 11.1% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after purchasing an additional 367 shares during the last quarter. Flinton Capital Management LLC increased its holdings in Envision Healthcare by 18.7% in the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after buying an additional 704 shares in the last quarter. D.A. Davidson & CO. increased its holdings in Envision Healthcare by 30.0% in the 2nd quarter. D.A. Davidson & CO. now owns 4,589 shares of the company’s stock worth $287,000 after buying an additional 1,059 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in Envision Healthcare by 1.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock worth $304,000 after buying an additional 70 shares in the last quarter.
TRADEMARK VIOLATION NOTICE: “Envision Healthcare (EVHC) Given a $40.00 Price Target by SunTrust Banks Analysts” was first reported by American Banking and Market News and is the sole property of of American Banking and Market News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2017/12/22/envision-healthcare-evhc-given-a-40-00-price-target-by-suntrust-banks-analysts.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
